Comparative Analysis of Direct Cold Atmospheric Plasma Treatment vs. Plasma Activated Water for the Deactivation of Omicron Variant of SARS-CoV-2

Cold atmospheric plasma (CAP) has gaining potential, and very effective to curb or deactivate the various microorganisms such as bacteria and virus. Lately, the major outbreak SARS-CoV-2 infection has affected humanity largely with added complexity of its ability to mutate to variants such as Omicron. We have earlier shown the effectiveness of CAP on SARS-CoV-2 spike protein and, in this study, we have evaluated the effectiveness of CAP to deactivate Omicron. We studied the ability of the binding of Angiotensin converting Enzyme Protein (ACE2) protein to the plasma treated spike S1-S2 protein and spike Receptor binding domain (RBD) using Cold atmospheric plasma direct treatment as well as Plasma activated water (PAW). Results have shown the binding efficiency of Omicron spike protein to ACE2 decrease with increase in treatment time with both direct treatment and PAW as evidenced using spectroscopic techniques. The reactive species (RONS) play a major role in the efficient deactivation of the binding of ACE2 to the Omicron spike protein. Correspondingly, the comparison between the efficiency between direct treatment and PAW has also been discussed.